We serve Chemical Name:4-Methyl-1H-benzimidazole-2-carboxylic acid CAS:673487-32-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Methyl-1H-benzimidazole-2-carboxylic acid
CAS.NO:673487-32-6
Synonyms:4-Methyl-1H-Benzimidazole-2-Carboxylic acid
Molecular Formula:C9H8N2O2
Molecular Weight:176.17200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:444.5ºC at 760 mmHg
Density:1.421g/cm3
Index of Refraction:1.709
PSA:65.98000
Exact Mass:176.05900
LogP:1.56950
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-Methyl-1H-Benzimidazole-2-Carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Methyl-1H-Benzimidazole-2-Carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Methyl-1H-Benzimidazole-2-Carboxylic acid Use and application,4-Methyl-1H-Benzimidazole-2-Carboxylic acid technical grade,usp/ep/jp grade.
Related News: Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report. 4-Methyl-1H-benzimidazole-2-carboxylic acid manufacturer The New York Times said that the batches being discarded amount to around 60 million doses, citing people familiar with the matter. 4-Methyl-1H-benzimidazole-2-carboxylic acid supplier Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report. 4-Methyl-1H-benzimidazole-2-carboxylic acid vendor The New York Times said that the batches being discarded amount to around 60 million doses, citing people familiar with the matter. 4-Methyl-1H-benzimidazole-2-carboxylic acid factory Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost.
